UroGen Pharma Ltd. 13F holders
190 funds reported a position in UroGen Pharma Ltd. in their 13F for the quarter ended 30 June 2026, together 42.4 million shares worth $1.56 billion. Against the quarter before, 38 opened a position, 61 added, 53 trimmed and 21 sold out; together they sold a net 4.0 million shares. The largest holders: RTW Investments, LP, BlackRock, Inc. and Morgan Stanley.
Funds holding190+17 on Q1 2026
Shares they held42.4Mworth $1.56 billion
Net sold on the quarter4.0M sharesabout $147.5 million at the funds' values
Funds buying to selling99 to 74opened or added, to cut or sold
Opened 38Added 61Held 38Trimmed 53Sold out 21
What each fund did in URGN against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in URGN in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 24 reported a position in UroGen Pharma Ltd.: 5 opened one, 11 added, 1 trimmed and 0 sold out, a net 93,746 shares bought.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Bender Robert & Associates | +34,701 | 34,701 | new | 13F |
| Hennion & Walsh Asset Management, Inc. | +32,888 | 309,584 | added | 13F |
| Wealth Enhancement Advisory Services, LLC | +12,649 | 20,291 | added | 13F |
| Oppenheimer & Co. Inc. | +7,696 | 7,696 | new | 13F |
| Kathmere Capital Management, LLC | +3,627 | 10,987 | added | 13F |
| Lanark Financial, Inc. | +1,184 | 1,184 | new | 13F |
| Sterling Capital Management LLC | +1,092 | 1,339 | added | 13F |
| Shikiar Asset Management Inc. | -1,000 | 7,750 | trimmed | 13F |
| Beacon Investment Advisory Services, Inc. | +250 | 250 | new | 13F |
| Gamma Investing LLC | +223 | 664 | added | 13F |
| SJS Investment Consulting Inc. | +108 | 108 | new | 13F |
| Nisa Investment Advisors, LLC | +94 | 689 | added | 13F |
| GF Fund Management Co. Ltd | +87 | 1,080 | added | 13F |
| Farther Finance Advisors, LLC | +58 | 82 | added | 13F |
| Brookstone Capital Management | +55 | 6,055 | added | 13F |
| SBI Securities Co., Ltd. | +33 | 39 | added | 13F |
| True Wealth Design, LLC | +1 | 17 | added | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 8 reported a position in UroGen Pharma Ltd. in a 13F for the quarter ended 30 June 2026. The largest: Point72 Asset Management, 1.5 million shares worth $56.1 million, 0.1% of its reported book. New this quarter: Point72 Asset Management, Renaissance Technologies. In the quarter, 4 funds added or opened a position and 4 trimmed or sold out; together they bought a net 1.2 million shares, about $43.1 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management | 1,525,549 | $56.1 million | 0.1% | +1,525,549 | new | 30 June 2026 | 13F |
| Geode Capital Management | 610,364 | $22.5 million | 0.0% | +86,533 | added | 30 June 2026 | 13F |
| FMR LLC | 197,098 | $7.3 million | 0.0% | +52,137 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 148,963 | $5.5 million | 0.0% | -28,938 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 106,692 | $3.9 million | 0.0% | -264,206 | trimmed | 30 June 2026 | 13F |
| ARK Investment Management | 101,508 | $3.7 million | 0.0% | -14,037 | trimmed | 30 June 2026 | 13F |
| Renaissance Technologies | 70,300 | $2.6 million | 0.0% | +70,300 | new | 30 June 2026 | 13F |
| Citadel Advisors | 12,985 | $477,848 | 0.0% | -255,011 | trimmed | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| RTW Investments, LP | 4,543,895 | 10.71% | $167.2 million | 1.43% | no change | 13F |
| BlackRock, Inc. | 3,201,461 | 7.55% | $117.8 million | 0.00% | +355,894 | 13F |
| Morgan Stanley | 2,576,363 | 6.07% | $94.8 million | 0.01% | +16,325 | 13F |
| Kynam Capital Management, LP | 2,434,207 | 5.74% | $89.6 million | 4.95% | +186,814 | 13F |
| Jefferies Financial Group Inc. | 2,199,652 | 5.18% | $80.9 million | 0.76% | no change | 13F |
| SG Americas Securities, LLC | 2,052,906 | 4.84% | $75.5 million | 0.04% | +395,060 | 13F |
| American Century Companies Inc. | 1,685,719 | 3.97% | $62.0 million | 0.03% | +48,149 | 13F |
| Acorn Capital Advisors, LLC | 1,673,420 | 3.94% | $61.6 million | 16.80% | no change | 13F |
| Point72 Asset Management, L.P. | 1,525,549 | 3.60% | $56.1 million | 0.09% | new | 13F |
| Frontier Capital Management Co. LLC | 1,508,547 | 3.56% | $55.5 million | 0.52% | +194,435 | 13F |
| Opaleye Management Inc. | 1,439,996 | 3.39% | $53.0 million | 4.80% | +9,996 | 13F |
| Silverarc Capital Management, LLC | 1,301,979 | 3.07% | $47.9 million | 5.33% | -201,066 | 13F |
| Menora Mivtachim Holdings Ltd | 1,152,531 | 2.72% | $42.4 million | 0.17% | no change | 13F |
| D. E. Shaw & Co., Inc. | 1,145,819 | 2.70% | $42.2 million | 0.03% | +122,660 | 13F |
| State Street Corp. | 1,003,071 | 2.36% | $36.9 million | 0.00% | +128,895 | 13F |
| MPM Bioimpact LLC | 933,415 | 2.20% | $34.3 million | 2.10% | -10,388 | 13F |
| Soleus Capital Management, L.P. | 829,810 | 1.96% | $30.5 million | 1.05% | +102,810 | 13F |
| Goldman Sachs Group Inc. | 819,834 | 1.93% | $30.2 million | 0.00% | +221,306 | 13F |
| Migdal Insurance & Financial Holdings Ltd. | 770,909 | 1.82% | $28.4 million | 0.18% | no change | 13F |
| Orbimed Advisors LLC | 676,187 | 1.59% | $24.9 million | 0.47% | -199,300 | 13F |
| Geode Capital Management, LLC | 610,364 | 1.44% | $22.5 million | 0.00% | +86,533 | 13F |
| Woodline Partners LP | 500,726 | 1.18% | $18.4 million | 0.06% | no change | 13F |
| Boxer Capital Management, LLC | 500,000 | 1.18% | $18.4 million | 1.39% | no change | 13F |
| Bank of America Corp. | 475,702 | 1.12% | $17.5 million | 0.00% | +348,919 | 13F |
| Vanguard Portfolio Management LLC | 456,558 | 1.08% | $16.8 million | 0.00% | +47,001 | 13F |
| Healthcare of Ontario Pension Plan Trust Fund | 387,074 | 0.91% | $14.2 million | 0.02% | no change | 13F |
| Northern Trust Corp. | 304,570 | 0.72% | $11.2 million | 0.00% | +28,632 | 13F |
| Rice Hall James & Associates, LLC | 300,650 | 0.71% | $11.1 million | 0.54% | +14,816 | 13F |
| Hennion & Walsh Asset Management, Inc. | 276,696 | 0.65% | $10.2 million | 0.29% | +93,192 | 13F |
| ADAR1 Capital Management, LLC | 252,395 | 0.59% | $9.3 million | 0.44% | -143,064 | 13F |
| J. Goldman & Co LP | 212,775 | 0.50% | $7.8 million | 0.28% | -726,095 | 13F |
| Privium Fund Management B.V. | 210,000 | 0.50% | $7.7 million | 1.42% | -28,122 | 13F |
| FMR LLC | 197,098 | 0.46% | $7.3 million | 0.00% | +52,137 | 13F |
| Superstring Capital Management LP | 191,313 | 0.45% | $7.0 million | 4.45% | -196,058 | 13F |
| Parkman Healthcare Partners LLC | 174,064 | 0.41% | $6.4 million | 0.66% | -100,936 | 13F |
| AQR Capital Management LLC | 149,228 | 0.35% | $5.5 million | 0.00% | +5,168 | 13F |
| Two Sigma Investments, LP | 148,963 | 0.35% | $5.5 million | 0.00% | -28,938 | 13F |
| Charles Schwab Investment Management Inc. | 128,370 | 0.30% | $4.7 million | 0.00% | +39,904 | 13F |
| UBS Group AG | 121,461 | 0.29% | $4.5 million | 0.00% | -38,197 | 13F |
| Elmind Capital, LP | 120,000 | 0.28% | $4.4 million | 1.11% | -100,000 | 13F |
| Wellington Management Group LLP | 115,362 | 0.27% | $4.2 million | 0.00% | +15,147 | 13F |
| Bank of New York Mellon Corp | 113,028 | 0.27% | $4.2 million | 0.00% | +14,086 | 13F |
| Voloridge Investment Management, LLC | 111,141 | 0.26% | $4.1 million | 0.02% | -119,489 | 13F |
| Aisling Capital Management LP | 108,000 | 0.25% | $4.0 million | 0.84% | no change | 13F |
| Millennium Management LLC | 106,692 | 0.25% | $3.9 million | 0.00% | -264,206 | 13F |
| Tidal Investments LLC | 101,837 | 0.24% | $3.7 million | 0.01% | -1,112 | 13F |
| ARK Investment Management LLC | 101,508 | 0.24% | $3.7 million | 0.02% | -14,037 | 13F |
| Russell Investments Group, Ltd. | 94,979 | 0.22% | $3.5 million | 0.00% | +31,733 | 13F |
| Nuveen, LLC | 92,102 | 0.22% | $3.4 million | 0.00% | +4,580 | 13F |
| Oak Ridge Investments LLC | 88,591 | 0.21% | $3.3 million | 0.18% | +2,188 | 13F |
The 50 largest of the 190 funds that reported a position in URGN in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on URGN
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 50,700 | $1.9 million | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 16,600 | $610,880 | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 27 October 2026 | 13G/A | BlackRock, Inc. and 1 other | 3.1 million | 6.3% | 30 September 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 August 2026 | 13G/A | The Toronto-Dominion Bank and 3 others | 3.3 million | 6.9% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G/A | Paradigm BioCapital Advisors LP and 7 others | 1.7 million | 3.5% | 31 March 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 15 May 2026 | 13G | The Toronto-Dominion Bank and 3 others | 2.6 million | 5.4% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 April 2026 | 13G | BlackRock, Inc. and 1 other | 2.5 million | 5.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 13 February 2026 | 13G/A | The Toronto-Dominion Bank and 1 other | 2.3 million | 4.9% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | Cowen Financial Products LLC and 1 other | 0 | 0.0% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 November 2025 | 13G/A | Paradigm BioCapital Advisors LP and 7 others | 4.2 million | 9.0% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 November 2025 | 13G | The Toronto-Dominion Bank and 1 other | 3.2 million | 6.9% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 25 September 2026 | 9,187 | $41.23 | SEC |
| 22 September 2026 | 1,328 | $43.20 | SEC |
| 17 August 2026 | 133 | $48.22 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.